在新诊断的扩散性大B细胞淋巴瘤中进行HIV,HBV和HCV检测:来自综合癌症中心的经验
C Natasha Kwendakwema1, Kristine F Lan2, H Nina Kim2
1Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA.
Clinical lymphoma, myeloma & leukemia
|January 6, 2026
概括
在接受治疗的扩散性大B细胞淋巴瘤 (DLBCL) 患者中,对艾滋病毒,乙型肝炎 (HBV) 和乙型肝炎 (HCV) 的查是不理想的. 提高病毒检测率可以降低DLBCL患者的治疗相关并发症和死亡率.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种常见的非霍奇金淋巴瘤.
- 艾滋病毒,HBV和HCV感染是DLBCL的风险因素,可能使治疗复杂化.
- 艾滋病毒阳性个体的DLBCL是致病率和死亡率的重要原因.
研究的目的:
- 在接受全身治疗的DLBCL患者中评估HIV,HBV和HCV的查率.
- 在这个患者群体中识别与病毒查相关的因素.
主要方法:
- 在2018年1月至2023年12月期间接受治疗的535名新诊断的DLBCL患者的回顾性分析.
- 患者被评估HBV,HCV和HIV测试或在定义的时间框架内先前诊断.
- 统计分析包括千平方,费舍尔精确和物流回归模型.
主要成果:
- 77%的患者进行了HBV检测,51.4%进行了HIV检测,53%进行了HCV检测.
- 年轻的患者更有可能接受HIV和HCV查.
- 年龄和HBV检测之间没有发现显著的关联.
结论:
- 在DLBCL患者中,HIV,HBV和HCV的治疗前查率低于最佳水平.
- 需要采取干预措施来提高病毒检测率.
- 增加查可以减少与治疗相关的发病率和死亡率.
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...


